Sangeeta N. Bhatia, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 16,758 shares at $166.08 ($2.8M) on 2019-10-02, disclosed to the SEC on 2019-10-04.
Open-market sale of $2.8M VRTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $166.08 | 1,960 | $326K | 11.6% |
| 2 | $166.08 | 1,960 | $326K | 11.6% |
| 3 | $166.82 | 5,187 | $865K | 31.0% |
| 4 | $166.82 | 5,187 | $865K | 31.0% |
| 5 | $167.88 | 1,232 | $207K | 7.4% |
| 6 | $167.88 | 1,232 |
| $207K |
| 7.4% |
| Total | $166.80 avg | 16,758 | $2.8M | 100% |
| Filing → |
| VRTX | SELL | 2025-08-29 | $206K | — | Filing → |
| VRTX | SELL | 2025-05-05 | $202K | — | Filing → |
| VRTX | SELL | 2024-09-04 | $323K | — | Filing → |